501 filings
Page 6 of 26
8-K
wddjhe1ttewpcqsdhc
3 May 18
Submission of Matters to a Vote of Security Holders
8:30am
8-K
8wgm5h8hx 497ivn
30 Apr 18
Allergan Reports 3% Increase in First Quarter 2018 GAAP Net Revenues to $3.7 Billion
7:15am
DEFA14A
n1wld39 du9evb
16 Apr 18
Additional proxy soliciting materials
12:00am
DEFA14A
dwq lgr8e3uw080belr
9 Apr 18
Additional proxy soliciting materials
12:00am
DEFA14A
j7nm5k
6 Apr 18
Additional proxy soliciting materials
12:00am
DEFA14A
w0oi kao1
23 Mar 18
Additional proxy soliciting materials
12:00am
25-NSE
rzqfs5kq
1 Mar 18
Exchange delisting
12:00am
S-3ASR
d53zn
16 Feb 18
Automatic shelf registration
12:00am
8-K
ni7ij
9 Feb 18
Other Events
12:00am
8-K
29ctv8o7m9g11
6 Feb 18
Allergan Reports Solid Finish to 2017 with 12% Increase in Fourth Quarter GAAP Net Revenues to $4.3 Billion
12:00am
8-K
3hr65nv49iooywzfv6p
5 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
mfog3uq7o3av6tce
1 Feb 18
Results of Operations and Financial Condition
12:00am
SC TO-T/A
lxcbntfwaid07qhd
30 Jan 18
Third party tender offer statement (amended)
12:00am
8-K
qhxi2wdg
8 Jan 18
Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference
12:00am
SC TO-T/A
g08d2hf
5 Jan 18
Third party tender offer statement (amended)
12:00am
SC TO-T/A
dxbc9e69i npg
4 Jan 18
Third party tender offer statement (amended)
12:00am